Close

William Blair Downgrades Portola Pharmaceuticals (PTLA) to Market Perform

May 5, 2020 11:55 AM EDT Send to a Friend
William Blair analyst Matt Phipps downgraded Portola Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login